Imaging Canada Liquidating Corp, formerly IMRIS Inc (IMRIS), is a Canada-based company, which designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and precision in treatment. It can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in various configurations. IMRIS sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. Its VISIUS iMRI provides imaging using Siemens 1.5T (tesla) and 3T MR core technology to enable imaging capabilities, including spectroscopy, fMRI and DTI. Its SYMBIS Surgical System is an MR and CT-compatible image guided surgical robot. Its VISIUS iCT is a multifunctional surgical theater that brings CT image quality with low dose management directly to patients in the operating room.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: TSE:IM
- CUSIP: N/A
- Web: N/A
- Trailing P/E Ratio:
- P/E Growth:
- Net Margins: -73.94%
- Return on Equity: -213.57%
- Return on Assets: -45.35%
Frequently Asked Questions for IMRIS (TSE:IM)
What is IMRIS's stock symbol?
IMRIS trades on the Tornton Stock Exchange (TSX) under the ticker symbol "IM."
Who are some of IMRIS's key competitors?
Some companies that are related to IMRIS include Colliers International Group (CIG), Kirkland Lake Gold Ltd (NMI), Osisko Mining Corp (OBM), Royal Bank of Canada (RY), Bank of Nova Scotia (BNS), Enbridge (ENB), Canadian National Railway Company (CNR), Suncor Energy (SU), Bank of Montreal (BMO), TransCanada (TRP), BCE (BCE), Manulife Financial Corp. (MFC), Canadian Imperial Bank of Commerce (CM), Canadian Natural Resources Limited (CNQ), Thomson Reuters Corp (TRI), Great-West Lifeco (GWO), Imperial Oil Ltd (IMO) and Sun Life Financial (SLF).
How do I buy IMRIS stock?
Shares of IMRIS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is IMRIS's stock price today?
MarketBeat Community Rating for IMRIS (TSE IM)MarketBeat's community ratings are surveys of what our community members think about IMRIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of IMRIS stock can currently be purchased for approximately C$0.80.
Consensus Ratings for IMRIS (TSE:IM) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for IMRIS (TSE:IM)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for IMRIS (TSE:IM)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for IMRIS (TSE:IM)
Current Year EPS Consensus Estimate: $-0.21 EPS
Dividend History for IMRIS (TSE:IM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for IMRIS (TSE:IM)Insider Trades by Quarter for IMRIS (TSE:IM)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Headline Trends for IMRIS (TSE:IM)
Latest Headlines for IMRIS (TSE:IM)
IMRIS (IM) Chart for Wednesday, July, 26, 2017